Loading…
CapsoVision, Inc. is projected to rise to $6.72 by 2027, a +12% move from its current price of $5.99. CV is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $5.70 | $5.99 | $6.30 | -0.01% |
| Jul 14 | $5.58 | $5.99 | $6.43 | -0.02% |
| Jul 15 | $5.49 | $5.99 | $6.53 | -0.03% |
| Jul 16 | $5.42 | $5.99 | $6.62 | -0.04% |
| Jul 17 | $5.35 | $5.99 | $6.70 | -0.05% |
| Jul 18 | $5.30 | $5.99 | $6.77 | -0.06% |
| Jul 19 | $5.24 | $5.99 | $6.83 | -0.07% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.24 | $5.99 | $6.83 | -0.07% |
| Week 2 | $4.96 | $5.98 | $7.21 | -0.13% |
| Week 3 | $4.75 | $5.98 | $7.52 | -0.20% |
| Week 4 | $4.58 | $5.97 | $7.78 | -0.26% |
| Week 5 | $4.44 | $5.97 | $8.03 | -0.33% |
| Week 6 | $4.31 | $5.97 | $8.25 | -0.39% |
| Week 7 | $4.20 | $5.96 | $8.46 | -0.46% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CapsoVision, Inc. is a medical technology company that manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).
It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products.
CapsoVision, Inc. (CV) is a healthcare stock with a current price of $6.13 and a market capitalization of $306.03M. It is ranked 3486 by market cap in its sector. The stock’s price outlook is established by a year-by-year forecast that shows modest upside in the near term and substantial upside in the long term.
The 2026 forecast shows a min of $4.64, an average of $6.13, and a max of $9.29, with a neutral sentiment. From 2027 onward the forecast unfolds a bullish trajectory, with higher average prices and progressively larger potential upside through 2050.
By 2050, the forecast envisions an average price of $113.18 with a max of $260.32 and a sizable cumulative upside, illustrating a multi-year bullish run despite earlier volatility.
A major floor 24.8% below — a decisive break under it would weaken the trend.
The nearest floor, 5.3% below — buyers have tended to step in here.
The nearest ceiling, 26.5% above — a clean break opens room to run.
A major ceiling 45.1% above — clearing it would confirm fresh momentum.
Key CV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.03 | Sell | $6.15 | Sell |
| MA 10 | $6.75 | Sell | $6.44 | Sell |
| MA 20 | $6.78 | Sell | $6.67 | Sell |
| MA 50 | $6.88 | Sell | $6.73 | Sell |
| MA 100 | $6.44 | Sell | $6.61 | Sell |
| MA 200 | $6.47 | Sell | $6.21 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.83 | Neutral |
| Stoch RSI (14) | 26.21 | Neutral |
| CCI (20) | -107.30 | Sell |
| Williams %R (14) | -83.25 | Info |
| MACD (12,26,9) | -0.16 | Sell |
| ROC (12) | -7.85 | Sell |
| Bollinger %B (20,2) | 0.15 | Neutral |
| Stochastic %K (14) | 16.75 | Buy |
| TRIX (15) | -0.08 | Sell |
| Awesome (5,34) | -0.81 | Sell |
| Ultimate (7,14,28) | 31.82 | Neutral |
| Momentum (10) | -1.00 | Sell |
| Aroon Osc (25) | -16.00 | Sell |
| Hull MA (9) | 5.51 | Buy |
| ADX (14) | 14.06 | Neutral |
| ATR (14) | 0.31 | Info |
The 30-day technical picture is NEUTRAL. The RSI(14) sits at 40, with the 50-day simple moving average at $6.90 and the 200-day simple moving average at $6.45. Short-term support is placed at $5.67 and resistance at $7.58. The stock has traded within a 30-day range of $4.37 to $8.58, indicating a broad but bounded trading band in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.64 | $5.99 | $8.93 | 0% | Neutral | |
| $4.66 | $6.72 | $10.49 | +12% | Neutral | |
| $5.00 | $7.78 | $13.08 | +30% | Bullish | |
| $6.40 | $10.66 | $18.95 | +78% | Bullish | |
| $7.88 | $13.99 | $26.02 | +134% | Bullish | |
| $8.71 | $16.39 | $31.71 | +174% | Bullish | |
| $7.57 | $15.10 | $30.23 | +152% | Bullish | |
| $7.50 | $15.82 | $32.67 | +164% | Bullish | |
| $8.40 | $18.66 | $39.63 | +212% | Bullish | |
| $8.73 | $19.39 | $42.25 | +224% | Bullish | |
| $13.87 | $30.82 | $70.88 | +415% | Bullish | |
| $40.51 | $90.02 | $207.04 | +14.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.64 | $5.99 | $7.41 | +0.00% |
| August 2026 | $4.70 | $5.75 | $7.38 | -3.94% |
| September 2026 | $4.76 | $5.94 | $7.81 | +3.21% |
| October 2026 | $5.10 | $6.45 | $8.67 | +8.65% |
| November 2026 | $5.08 | $6.52 | $8.90 | +0.97% |
| December 2026 | $4.96 | $6.43 | $8.93 | -1.28% |
Click any year to see its month-by-month CV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CV to range from $4.64 to $8.93 through 2026. The $5.99 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The CV price prediction for 2027 points to an average of $6.72 (low $4.66, high $10.49) — a potential gain of +12% on today's $5.99. A consolidation phase looks the most probable path here.
In 2028, CV is projected to trade between $5.00 and $13.08, averaging $7.78 — a potential gain of +30% from today's $5.99. That is up +16% on the projected 2027 average. Momentum favours further upside here.
CapsoVision, Inc.'s 2029 outlook centres on $10.66, within a $6.40 to $18.95 range. That is up +37% on the projected 2028 average. That marks a +78% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, CV could reach as high as $26.02, with a base case around $13.99 and support toward $7.88 — roughly +134% from $5.99. Momentum favours further upside here.
Expect CV to range from $8.71 to $31.71 through 2031. The $16.39 average target implies a +174% move from current prices. That is up +17% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The CV price prediction for 2032 points to an average of $15.10 (low $7.57, high $30.23) — a potential gain of +152% on today's $5.99. Momentum favours further upside here.
In 2033, CV is projected to trade between $7.50 and $32.67, averaging $15.82 — a potential gain of +164% from today's $5.99. That is up +5% on the projected 2032 average. Buyers look set to stay in control over this stretch.
CapsoVision, Inc.'s 2034 outlook centres on $18.66, within a $8.40 to $39.63 range. That is up +18% on the projected 2033 average. That marks a +212% change versus current levels. Momentum favours further upside here.
By 2035, CV could reach as high as $42.25, with a base case around $19.39 and support toward $8.73 — roughly +224% from $5.99. Buyers look set to stay in control over this stretch.
Expect CV to range from $13.87 to $70.88 through 2040. The $30.82 average target implies a +415% move from current prices. That is up +59% on the projected 2035 average. Momentum favours further upside here.
The CV price prediction for 2050 points to an average of $90.02 (low $40.51, high $207.04) — a potential gain of +14.0x on today's $5.99. Buyers look set to stay in control over this stretch.
Investing $1,000 in CV today (≈ 166.944908 CV) could be worth
$15,028.16
+$14,028.16 (+1403%) by 2050 · US Dollar
Based on the average projected CV price of $90.02 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CVwould be worth at today's price.
$1,000 invested in CV on Jul 10, 2025 (≈ 222.222222 CV) would be worth
$1,331.11
+$331.11 (+33.1%) today · 1.33× · US Dollar
Based on a CV entry price of $4.5 vs. today's $5.99.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.28 | $822.8 | -17.7% |
| 1 month ago | $7.24 | $827.35 | -17.3% |
| 3 months ago | $6.25 | $958.4 | -4.2% |
| 6 months ago | $6 | $998.33 | -0.2% |
| 1 year ago | $4.5 | $1,331.11 | +33.1% |
| All time (1.0y) ago | $3.5 | $1,711.43 | +71.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CV forecast.
Our base-case forecast reaches $12.00 around 2030.
Implied market cap at $12.00: $599.56M
The multi-year forecast shows a clear bullish trajectory after a flat start in 2026. In 2027 the average price is projected at $7.11 with a 16 ROI; in 2028 the average rises to $8.37 (36.7 ROI); and 2029 shows an average of $11.94 (94.9 ROI). The ability to reach higher price levels continues, with 2030 expected to average $15.73 and deliver a 156.8 ROI, and 2031 at $18.35 (199.5 ROI).
2032 and 2033 also remain bullish with averages of $17.13 and $18.19 and ROI of 179.6 and 197 respectively. The trajectory accelerates further in 2034 at $21.61 (252.8 ROI) and 2035 at $23.12 (277.5 ROI). By 2040 the average price is forecast at $36.87 with a 502 ROI, and by 2050 the average reaches $113.18 with a max of $260.32 and a remarkable 1747.8 ROI.
These figures reflect a long-run bullish outlook, but they are estimates and not guarantees. Risks and uncertainty remain inherent in future price movements.
Tap a question to reveal the answer.
In 2030 the forecast shows an average price of $15.73, with a min of $8.74 and a max of $29.54, and a ROI of 156.8. The sentiment is BULLISH.
The forecast shows a bullish trajectory from 2027 onward with rising averages and positive ROIs (e.g., 2027 ROI 16; 2028 ROI 36.7; 2029 ROI 94.9; 2030 ROI 156.8; 2050 ROI 1747.8). These are estimates and carry inherent investment risk.
Yes. The forecast for 2050 shows a max of $260.32 with an average of $113.18 and a ROI of 1747.8, indicating potential to reach very high price levels over the long term.
Current price is $6.13. The 30-day range is $4.37 to $8.58, with a 30-day sentiment of NEUTRAL, RSI(14) at 40, SMA50 at $6.90, SMA200 at $6.45, support at $5.67, and resistance at $7.58.
RSI(14) is 40, SMA50 is $6.90, SMA200 is $6.45, with support at $5.67 and resistance at $7.58. The 30-day range spans $4.37 to $8.58, and the overall sentiment is NEUTRAL.
CapsoVision, Inc. Community Discussion
0Share your CapsoVision, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.